肝动脉直径预测胃食管静脉曲张治疗后出血风险:一项增强CT研究
回顾性纳入258例肝硬化患者,测试队列199例为GOV治疗前,验证队列59例为GOV治疗后,在增强CT动脉期冠状面测量肝动脉中点直径。测试队列高危险GOV的肝动脉直径显著高于低危险GOV,以4.06 mm为截断值识别出血风险的AUC为0.940,验证队列敏感度0.885、特异度0.939。
要点
- 增强CT动脉期冠状面测量肝动脉中点直径可用于识别GOV治疗后的出血风险。
- 肝动脉直径4.06 mm为识别出血风险的最佳截断值,测试队列AUC 0.940。
- 高危险GOV肝动脉直径4.69(4.31, 5.56)mm,高于低危险GOV的3.10(2.59, 3.77)mm。
核心结论
- 肝动脉直径在识别GOV治疗后出血风险方面具有较高的诊断效能。
研究设计与样本
- 回顾性研究,共258例肝硬化患者,测试队列为GOV治疗前患者199例,验证队列为GOV治疗后患者59例,采用增强CT动脉期图像行冠状面重建并测量肝动脉中点直径,以 endoscopic findings 分级和出血风险为参考标准。
诊断标准与关键数值
- 测试队列中,以肝动脉直径4.06 mm为截断值识别出血风险,AUC为0.940(95%CI 0.908-0.972),敏感度0.887、特异度0.892、阳性预测值0.904、阴性预测值0.874;验证队列敏感度0.885、特异度0.939、阳性预测值0.920、阴性预测值0.912。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Portal hypertension leads to hepatic artery dilatation and a higher risk of bleeding. We tried to identify the bleeding risk after gastroesophageal varices (GOV) treatment using hepatic artery diameter of contrast-enhanced CT.
METHODS: Retrospective retrieval of 258 patients with cirrhosis who underwent contrast-enhanced CT from January 2022 to May 2023 and endoscopy within one month thereafter at Hainan Affiliated Hospital of Hainan Medical University. Cirrhotic patients before GOV treatment were used as the test cohort (n = 199), and cirrhotic patients after GOV treatment were used as the validation cohort (n = 59). The grading and bleeding risk was classified according to the endoscopic findings. Arterial-phase images of contrast-enhanced CT were used for coronal reconstruction, and the midpoint diameter of the hepatic artery was measured on coronal images. The optimal cutoff value for identifying bleeding risk was analyzed and calculated in the test cohort, and its diagnostic performance was evaluated in the validation cohort.
RESULTS: In the test cohort, hepatic artery diameters were significantly higher in high-risk GOV than in low-risk GOV [4.69 (4.31, 5.56) vs. 3.10 (2.59, 3.77), P < 0.001]. With a hepatic artery diameter cutoff value of 4.06 mm, the optimal area under the operating characteristic curve was 0.940 (95% confidence interval: 0.908-0.972), with a sensitivity of 0.887, a specificity of 0.892, a positive predictive value of 0.904, and a negative predictive value of 0.874 for identifying bleeding risk in the test cohort, while in the validation cohort, the sensitivity was 0.885, specificity was 0.939, positive predictive value was 0.920, and negative predictive value was 0.912.
CONCLUSION: Hepatic artery diameter has high diagnostic performance in identifying bleeding risk after GOV treatment.
引用
- Li G, Cai Q, Qin X, et al. Hepatic artery diameter predicts bleeding risk after gastroesophageal varices treatment: a contrast-enhanced CT study. Abdom Radiol (NY). 2024. PMID: 38619612. doi:10.1007/s00261-024-04291-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。